Identification and analysis of anti-HDL scFv-antibodies obtained from phage display based synthetic antibody library

Priyanka Negi1, Janita Lövgren1, Päivi Malmi1

  • 1Department of Biochemistry, Division of Biotechnology, University of Turku, Turku, Finland.

Clinical Biochemistry
|December 15, 2015
PubMed

Insights

Researchers developed novel antibodies targeting high-density lipoprotein cholesterol (HDL-C) for potential coronary artery disease (CAD) risk assessment. These antibodies show promise as research tools and in diagnostic methods for CAD.

Area of Science:

  • Immunology
  • Cardiovascular Research
  • Biotechnology

Background:

  • Plasma high-density lipoprotein cholesterol (HDL-C) levels inversely correlate with atherosclerotic cardiovascular events.
  • HDL comprises subpopulations with varying anti-atherogenic properties.
  • Coronary artery disease (CAD) diagnosis and risk assessment require improved biomarkers.

Purpose of the Study:

  • To isolate coronary artery disease (CAD) specific single-chain variable fragment (scFv) antibodies targeting high-density lipoprotein (HDL).
  • To characterize the binding profiles of these novel anti-HDL antibodies.
  • To evaluate their potential utility in CAD risk assessment.

Main Methods:

  • Phage displayed synthetic antibody libraries were used to enrich for HDL binders from CAD patients.
  • Antibodies were affinity purified and characterized using time-resolved fluorescence-based immunoassay.
  • Binding to apolipoproteins A-I and A-II, various HDL forms, and plasma HDL was assessed.

Main Results:

  • 1200 HDL-binding clones were obtained, yielding 264 unique antibodies after sequencing.
  • 61 antibodies were selected for further analysis, revealing diverse binding profiles.
  • Several antibodies demonstrated specificity for HDL from CAD patients and recognized HDL in plasma.

Conclusions:

  • Novel HDL-recognizing antibodies were successfully isolated using synthetic antibody phage libraries.
  • These antibodies exhibit unique binding characteristics, suitable for research applications.
  • A subset of these antibodies holds potential for developing diagnostic methods for CAD risk assessment.
Abstract